Statement

On the establishment of research centers to initiate local vaccine development


The President will review the recommendations of the Department of Science and Technology (DOST) to establish the Pharmaceutical Development Center and the Virology Science and Technology Institute of the Philippines, which have already been approved by the Inter-Agency Task Force (IATF) last Friday, May 22.

If and once approved by PRRD, both can start in 2020, with the Pharmaceutical Group and the Virology Research Group evolving out of DOST’s Industrial Technology Development Institute (ITDI).

We understand that the DOST has included the establishment of the aforesaid research centers in its 2021 Budget Proposal.